(3R,4R)-(3-HYDROXY-PIPERIDIN-4-YL)-CARBAMIC ACID TERT-BUTYL ESTER, 95.0%, 250mg

Z-DL-Ala-Gly-OH, 99.0%, 1g

DAPAGLIFLOZIN, 98%, 250mg

2-(3-HYDROXY-4-METHOXYPHENYL)ACETONITRILE, 95.0%, 250mg

Ethyl 2-bromo-4-fluorobenzoate, 98.0%, 25g

5-Iodo-o-anisidine, 97.0%, 500g

2-(1,3-Dioxolan-2-yl)ethylmagnesium bromide (0.50 M in 2-MeTHF), 100ml

Nepsilon-(2,4-Dinitrophenyl)-L-lysine Hydrochloride>98.0%(HPLC)1g

L-Lysine, N2,N6-bis[(9H-fluoren-9-ylmethoxy)carbonyl]-, 2,3,4,5,6-pentafluorophenyl ester, 95%, 250mg

(3R,4R)-tert-Butyl 3-((tert-butoxycarbonyl)amino)-4-hydroxypyrrolidine-1-carboxylate, 97.0%, 1g

7-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole, 95.0%, 25g

4-(BOC-AMINOMETHYL)PYRAZOLE, 95.0%, 250mg

H-HIS(3-ME)-OH, 97.0%, 100mg